EpiPen Products Recalled Due to Device Failure

APRIL 03, 2017
Jennifer Barrett, Assistant Editor

The FDA issued an alert warning consumers of a nationwide voluntary recall of Mylan’s EpiPen and EpiPen JR (epinephrine injection) Auto-Injector products due to a potentially defective part that may result in device failure. The products are intended for use as an emergency treatment for severe allergic reactions.
The recall is due to 2 previously disclosed reports outside of the United States of the device’s failure to activate as a result of a possible defect in a supplier component. The defect’s incidence was limited to a single lot, but additional lots have also been recalled as a precautionary measure. The recall affects the 0.3-mg and 0.15-mg strengths, and none of the recalled lots include the authorized generic version for EpiPen Auto-Injector.
According to the FDA’s press release, Mylan intends to replace recalled devices for patients at no cost, and patients should keep their existing products until they can receive a replacement. Patients can obtain an EpiPen Auto-Injector or its authorized generic at a pharmacy as a replacement based on availability.
The recalled product was manufactured by Meridian Medical Technologies, a Pfizer company, and distributed by Mylan Specialty between December 2015 and July 2016.
Mylan Provides Update on Meridian Medical Technologies', a Pfizer Company, Expanded Voluntary Worldwide Recall of EpiPen® Auto-Injector [news release]. FDA’s website. https://www.fda.gov/Safety/Recalls/ucm550173.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery. Accessed April 3, 2017. 


A Fast, Easy Way to Inform Parents About Vaccinations

Officials with the Centers for Disease Control and Prevention have prepared an informational video on this topic.

Pharmacy Times Strategic Alliance

Pharmacist Education
Clinical features with downloadable PDFs

Next-Generation Pharmacist® Awards

Personalize the information you receive by selecting targeted content and special offers.